Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab

Seminars in Oncology · Elsevier

Аннотация

Publication date: December 2026 Source: Seminars in Oncology, Volume 53, Issue 6 Author(s): Margherita Rimini, Simone Rocchetto, Eleonora Alimenti, Giuseppe Cabibbo, Lorenza Rimassa, David J. Pinato, Alessandro Vitale, Francesca R. Ponziani, Silvia Camera, Mara Persano, Pietro Lampertico, Andrea Casadei-Gardini, Massimo Iavarone

Читать у издателя →

Похожие статьи